Olatoyosi Odenike to Maleimides
This is a "connection" page, showing publications Olatoyosi Odenike has written about Maleimides.
Connection Strength
0.139
-
An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia. Leuk Lymphoma. 2016 08; 57(8):1800-6.
Score: 0.139
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.